映恩生物-B(09606)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09606 映恩生物-B

已收盘 02-02 16:08:06

317.600

-12.200

-3.70%

最高333.800	最低310.000	成交量55.82万
今开323.000	昨收329.800	日振幅7.22%
总市值283.98亿	流通市值283.98亿	总股本8,942万
成交额1.76亿	换手率0.62%	流通股本8,942万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"映恩生物-B","latestPrice":317.6,"timestamp":1770019686005,"preClose":329.8,"halted":0,"volume":558159,"delay":0,"changeRate":-0.03699211643420251,"floatShares":89415400,"shares":89415400,"eps":-131.30424,"marketStatus":"已收盘","change":-12.2,"latestTime":"02-02 16:08:06","open":323,"high":333.8,"low":310,"amount":176498075,"amplitude":0.072165,"askPrice":317.6,"askSize":600,"bidPrice":315.8,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-34.716,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770082200000},"marketStatusCode":5,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":329.8,"openAndCloseTimeList":[[1769995800000,1770004800000],[1770008400000,1770019200000]],"volumeRatio":1.08399,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09606","defaultTab":"news","newsList":[{"id":"2607648017","title":"每日卖空追踪 | 映恩生物-B 01月30日卖空量成交1.76万股，卖空比例为2.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607648017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607648017?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:30","pubTimestamp":1769761843,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间01月30日，跌2.19%，卖空量成交1.76万股，较上一交易日减少28.16%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130164213a6bf4fbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130164213a6bf4fbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","09606","HK0000500386.USD","LU2543165471.USD","HK0000252152.HKD","BK1161"],"gpt_icon":0},{"id":"2607017674","title":"映恩生物-B盘中异动 股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607017674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607017674?lang=zh_cn&edition=full","pubTime":"2026-01-30 09:31","pubTimestamp":1769736699,"startTime":"0","endTime":"0","summary":"2026年01月30日早盘09时31分，映恩生物-B股票出现波动，股价急速上涨5.22%。截至发稿，该股报354.800港元/股，成交量9.3733万股，换手率0.10%，振幅6.23%。映恩生物-B股票所在的生物技术行业中，整体跌幅为0.76%。其相关个股中，同源康医药-B、百奥赛图-B、诺诚健华涨幅较大，振幅较大的相关个股有百奥赛图-B、诺诚健华、维亚生物，振幅分别为11.00%、7.06%、6.67%。映恩生物-B公司简介：映恩生物是一家主要从事临床阶段生物制药的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026013009313997a40e5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026013009313997a40e5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252152.HKD","LU2543165471.USD","09606","HK0000252160.HKD","BK1161","HK0000500386.USD"],"gpt_icon":0},{"id":"2606714347","title":"映恩生物-B01月28日主力净流入1097.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2606714347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606714347?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:15","pubTimestamp":1769588152,"startTime":"0","endTime":"0","summary":"01月28日, 映恩生物-B股价涨3.07%，报收349.00元，成交金额2.2亿元，换手率0.70%，振幅6.08%，量比1.07。映恩生物-B今日主力资金净流入1097.0万元，上一交易日主力净流出373.6万元。该股近5个交易日下跌0.06%，主力资金累计净流入885.6万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入2.5亿元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162313a45f74c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162313a45f74c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","BK1161","LU2543165471.USD","HK0000252152.HKD","HK0000500386.USD","HK0000252160.HKD"],"gpt_icon":0},{"id":"2606754215","title":"每日卖空追踪 | 映恩生物-B 01月27日卖空量成交4.49万股，卖空比例为7.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606754215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606754215?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:30","pubTimestamp":1769502644,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间01月27日，涨5.42%，卖空量成交4.49万股，较上一交易日增加81.78%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164256a6b23a1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164256a6b23a1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000252152.HKD","LU2543165471.USD","HK0000500386.USD","HK0000252160.HKD","09606"],"gpt_icon":0},{"id":"2606840208","title":"港股异动 | 映恩生物-B(09606)涨超6% 公司2026年临床数据有望密集读出","url":"https://stock-news.laohu8.com/highlight/detail?id=2606840208","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606840208?lang=zh_cn&edition=full","pubTime":"2026-01-27 14:24","pubTimestamp":1769495043,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，映恩生物-B涨超6%，截至发稿，涨6.04%，报340.6港元，成交额1.54亿港元。该药物是第5款进入III期阶段的B7-H3 ADC。BNT324是映恩生物开发的一款B7-H3 ADC，于2023年4月被授权至BioNTech，该公司拥有该药物在中国以外的开发、生产和商业化权益。国联民生证券指出，2026年ADC+IO与核心单药临床数据集中读出。该行认为，映恩生物引领ADC迭代浪潮，2026年有望迎来商业化。映恩生物持续开发下一代新型ADC，包括双抗ADC，全新机制载荷ADC和自免ADC。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000252160.HKD","09606","BK1161","HK0000252152.HKD","LU2543165471.USD","HK0000500386.USD"],"gpt_icon":0},{"id":"2606272282","title":"华福证券：医药生物业新技术全面突破 战略看多中国创新出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2606272282","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606272282?lang=zh_cn&edition=full","pubTime":"2026-01-27 11:01","pubTimestamp":1769482871,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华福证券发布研报称，2025年中国创新药全球竞争力凸显，出海交易创新高，多家企业扭亏为盈。战略看多中国创新出海。华福证券主要观点如下：国内复盘：全球竞争力凸显，企业扭亏为盈+管线出海价值新高度2025创新药指数大涨，Biopharma和Biotech持仓比例显著提升，核心驱动因素是中国创新药全球竞争力凸显。创新药市场份额快速提升，肿瘤与免疫领域创新药份额超32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127110355a6b10694&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127110355a6b10694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02615","01093","06978","06955","HK0000165453.HKD","BK1161","BK1583","06938","01801","01672","06160","BK1593","BK1574","09606","01276","01530","02157","09926","02162","02096","09887"],"gpt_icon":0},{"id":"2606727437","title":"每日卖空追踪 | 映恩生物-B 01月26日卖空量成交9400股，卖空比例为2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606727437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606727437?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:30","pubTimestamp":1769416242,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间01月26日，跌4%，卖空量成交9400股，较上一交易日减少39.74%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164239a456cb1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164239a456cb1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","09606","HK0000500386.USD","LU2543165471.USD","HK0000252152.HKD","BK1161"],"gpt_icon":0},{"id":"2606274397","title":"映恩生物-B01月26日主力净流出2.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2606274397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606274397?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:15","pubTimestamp":1769415356,"startTime":"0","endTime":"0","summary":"01月26日, 映恩生物-B股价跌4.00%，报收321.20元，成交金额1.5亿元，换手率0.52%，振幅7.05%，量比0.76。映恩生物-B今日主力资金净流出2.6万元，上一交易日主力净流入716.9万元。该股近5个交易日下跌9.30%，主力资金累计净流出1809.5万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入2.2亿元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126162333a6ad6421&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126162333a6ad6421&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","LU2543165471.USD","HK0000500386.USD","HK0000252152.HKD","BK1161","09606"],"gpt_icon":0},{"id":"2605883252","title":"每日卖空追踪 | 映恩生物-B 01月23日卖空量成交7400股，卖空比例为1.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605883252","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605883252?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:30","pubTimestamp":1769157042,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间01月23日，涨3.91%，卖空量成交7400股，较上一交易日减少66.82%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123164134a6a44f49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123164134a6a44f49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","LU2543165471.USD","HK0000252160.HKD","BK1161","HK0000252152.HKD","HK0000500386.USD"],"gpt_icon":0},{"id":"2605424389","title":"映恩生物-B盘中异动 股价大涨5.09%报338.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605424389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605424389?lang=zh_cn&edition=full","pubTime":"2026-01-23 09:47","pubTimestamp":1769132824,"startTime":"0","endTime":"0","summary":"2026年01月23日早盘09时47分，映恩生物-B股票出现波动，股价急速拉升5.09%。截至发稿，该股报338.400港元/股，成交量10.27万股，换手率0.11%，振幅5.03%。资金方面，该股资金流入2488.53万港元，流出631.19万港元。映恩生物-B股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，来凯医药-B、中生北控生物科技、昭衍新药涨幅较大，振幅较大的相关个股有中生北控生物科技、百奥赛图-B、来凯医药-B，振幅分别为15.00%、9.32%、8.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012309470497a30844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012309470497a30844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000500386.USD","09606","BK1161","HK0000252152.HKD","HK0000252160.HKD","LU2543165471.USD"],"gpt_icon":0},{"id":"2605268284","title":"每日卖空追踪 | 映恩生物-B 01月22日卖空量成交1.38万股，卖空比例为1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605268284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605268284?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:30","pubTimestamp":1769070641,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间01月22日，跌8.05%，卖空量成交1.38万股，较上一交易日减少44.35%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122163844a4491ed1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122163844a4491ed1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","HK0000252152.HKD","HK0000500386.USD","HK0000252160.HKD","BK1161","09606"],"gpt_icon":0},{"id":"2604157635","title":"港股异动 | 映恩生物-B(09606)早盘涨超4% ADAM9靶向ADC癌症新药在中国获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2604157635","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604157635?lang=zh_cn&edition=full","pubTime":"2026-01-20 09:48","pubTimestamp":1768873737,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，映恩生物-B早盘涨超4%，截至发稿，涨2.42%，报363.6港元，成交额5105.75万港元。消息面上，1月19日，映恩生物宣布，公司自主研发的ADAM9靶向抗体偶联药物DB-1317已获得国家药监局药品审评中心的新药临床试验批准，同意其单药在晚期/转移性恶性实体瘤患者中开展临床试验。据悉，DB-1317是映恩生物基于公司自主研发的ADC技术平台DITAC开发的新一代ADC产品，具有全球权益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394864.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000252152.HKD","HK0000500386.USD","HK0000252160.HKD","LU2543165471.USD","BK4231","ADC","09606","BK1161","BK4080"],"gpt_icon":0},{"id":"2604189821","title":"生物制品行业深度报告：MNC不断加码IO双抗，2026年重磅催化有望持续","url":"https://stock-news.laohu8.com/highlight/detail?id=2604189821","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604189821?lang=zh_cn&edition=full","pubTime":"2026-01-19 12:07","pubTimestamp":1768795650,"startTime":"0","endTime":"0","summary":"MNC不断加码IO双抗，2026年重磅催化有望持续目前全球共18款PD-1/VEGF双抗进入临床阶段，其中5款国产已BD出海。依沃西单抗：国内注册临床HARMONi-2和HARMONi-6试验OS数据有望于2026年成熟。海外临床目前围绕NSCLC进行全面布局，2025H2新开一项针对一线结直肠癌患者的美国注册临床。RC148：荣昌生物于近期与艾伯维达成6.5亿美元首付款及最高达49.5亿美元里程碑付款的独家授权许可协议。辉瑞已于2025年底开展SSGJ-707联合ITGB6ADC的I/II期临床，2026年有望开展更多联合ADC的探索性临床。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119123139a43b4e4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119123139a43b4e4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09995","HK0000252160.HKD","LU2543165471.USD","09606","HK0000500386.USD","01541","01877","HK0000252152.HKD"],"gpt_icon":0},{"id":"2604978613","title":"医药生物行业：从投融资和JPM大会 看26年CXO投资机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2604978613","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604978613?lang=zh_cn&edition=full","pubTime":"2026-01-18 00:00","pubTimestamp":1768665600,"startTime":"0","endTime":"0","summary":"从最新投融资和JPM 大会，看26 年CXO 景气度趋势：一级：26M1 以来，海外一级市场投融资表现强劲。26M1 以来，投融资总金额为33.4 亿美元，仅半个月数据已超过23 年以来大部分月份整月金额，表明投融资进一步恢复好转！我们认为，2026 年CXO 板块的景气度仍将延续，重点关注板块内相关公司。从本周JPM 会议上看，CXO 对26 年的展望都很好，再次展现了业绩为王，另外短期进入25 年年报预增期，继续挖掘业绩能超预期的个股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260118152612a43867be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260118152612a43867be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1515","BK1576","BK1574","BK1583","BK1161","09606","03347","BK1141"],"gpt_icon":0},{"id":"2603984416","title":"每日卖空追踪 | 映恩生物-B 01月15日卖空量成交1.29万股，卖空比例为1.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603984416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603984416?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:30","pubTimestamp":1768465842,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间01月15日，涨0.78%，卖空量成交1.29万股，较上一交易日减少69.43%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164430a4c6d7ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164430a4c6d7ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","BK1161","HK0000500386.USD","09606","LU2543165471.USD","HK0000252152.HKD"],"gpt_icon":0},{"id":"2603844519","title":"映恩生物-B01月15日主力净流入6322.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2603844519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603844519?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:15","pubTimestamp":1768464950,"startTime":"0","endTime":"0","summary":"01月15日, 映恩生物-B股价涨0.78%，报收362.80元，成交金额4.5亿元，换手率1.38%，振幅5.83%，量比1.14。映恩生物-B今日主力资金净流入6322.5万元，上一交易日主力净流出1433.8万元。该股近5个交易日上涨2.82%，主力资金累计净流入7785.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2.0亿元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115162212a71db292&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115162212a71db292&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000500386.USD","LU2543165471.USD","BK1161","09606","HK0000252152.HKD","HK0000252160.HKD"],"gpt_icon":0},{"id":"2603861557","title":"映恩生物-B01月14日主力净流出1433.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2603861557","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603861557?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:15","pubTimestamp":1768378542,"startTime":"0","endTime":"0","summary":"01月14日, 映恩生物-B股价跌0.99%，报收360.00元，成交金额3.1亿元，换手率0.98%，振幅6.49%，量比0.76。映恩生物-B今日主力资金净流出1433.8万元，上一交易日主力净流入2057.7万元。该股近5个交易日上涨3.27%，主力资金累计净流入1.0亿元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.4亿元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114162026a7194f21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114162026a7194f21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","HK0000252160.HKD","HK0000500386.USD","BK1161","HK0000252152.HKD","LU2543165471.USD"],"gpt_icon":0},{"id":"2603639343","title":"每日卖空追踪 | 映恩生物-B 01月13日卖空量成交2.74万股，卖空比例为2.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603639343","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603639343?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:30","pubTimestamp":1768293041,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间01月13日，涨2.19%，卖空量成交2.74万股，较上一交易日减少30.81%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113165606a71509c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113165606a71509c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252152.HKD","LU2543165471.USD","BK1161","HK0000252160.HKD","HK0000500386.USD","09606"],"gpt_icon":0},{"id":"2603395386","title":"映恩生物-B01月13日获主力加仓2057.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603395386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603395386?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:15","pubTimestamp":1768292126,"startTime":"0","endTime":"0","summary":"01月13日, 映恩生物-B股价涨2.19%，报收363.60元，成交金额3.4亿元，换手率1.04%，振幅5.40%，量比0.80。映恩生物-B今日主力资金净流入2057.7万元，上一交易日主力净流入884.0万元。该股近5个交易日上涨7.00%，主力资金累计净流入1.6亿元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.5亿元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113161844a4bdee17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113161844a4bdee17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","BK1161","HK0000500386.USD","09606","LU2543165471.USD","HK0000252152.HKD"],"gpt_icon":0},{"id":"2603639533","title":"BioNTech携映恩ADC亮相JPM，BNT324将启动mCRPC三期","url":"https://stock-news.laohu8.com/highlight/detail?id=2603639533","media":"氨基观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603639533?lang=zh_cn&edition=full","pubTime":"2026-01-13 10:47","pubTimestamp":1768272472,"startTime":"0","endTime":"0","summary":"值得注意的是，BioNTech在报告中明确表示：“跟映恩合作开发的重点产品下一代B7H3 ADCBNT324/DB-1311，计划于2026年启动评估BNT324作为晚期转移性去势抵抗性前列腺癌一线治疗方案的III期临床试验。”此前在2025ASCO年会上公布的早期数据显示，BNT324/DB-1311在经多线治疗的mCRPC患者中展现出令人鼓舞的抗肿瘤活性和可管理的安全性，为进军一线治疗奠定了数据基础。BNT324/DB-1311已于此前获得美国FDA授予的快速通道资格，用于治疗化疗后的晚期/转移性CRPC。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113111423a713c8dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113111423a713c8dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","BK1161","HK0000500386.USD","09606","LU2543165471.USD","HK0000252152.HKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dualitybiologics.com","stockEarnings":[{"period":"1week","weight":-0.0143},{"period":"1month","weight":0.106},{"period":"3month","weight":0.0503},{"period":"6month","weight":0.0154},{"period":"1year","weight":2.4863},{"period":"ytd","weight":0.106}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":0.0685},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.1175},{"period":"1year","weight":0.3541},{"period":"ytd","weight":0.0685}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"映恩生物是一家主要从事临床阶段生物制药的投资控股公司。该公司致力于为癌症和自身免疫性疾病等患者研发抗体偶联药物（ADC）创新药物。该公司的主要候选药物产品包括DB-1303/BNT323、DB-1311/BNT324、DB-1310、DB-1305/BNT325、DB-1419和DB-2304。该公司的产品主要用于靶向治疗子宫内膜癌（EC）、乳腺癌（BC）、小细胞肺癌（SCLC）、去势抵抗性前列腺癌（CRPC）、食管鳞状细胞癌（ESCC）及头颈部鳞状细胞癌（HNSCC）。该公司主要在国内和国外市场开展业务。","exchange":"SEHK","name":"映恩生物-B","nameEN":"DUALITYBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"映恩生物-B(09606)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供映恩生物-B(09606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"映恩生物-B,09606,映恩生物-B股票,映恩生物-B股票老虎,映恩生物-B股票老虎国际,映恩生物-B行情,映恩生物-B股票行情,映恩生物-B股价,映恩生物-B股市,映恩生物-B股票价格,映恩生物-B股票交易,映恩生物-B股票购买,映恩生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"映恩生物-B(09606)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供映恩生物-B(09606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}